申请人:Altman Michael D.
公开号:US20140100250A1
公开(公告)日:2014-04-10
The present invention provides novel pyrimidine amines of formula I which are potent inhibitors of spleen tyrosine kinase, and are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD, rheumatoid arthritis, and cancer.
本发明提供了式I的新型嘧啶胺,其是脾酪氨酸激酶的有效抑制剂,并且在治疗和预防由该酶介导的疾病,如哮喘、COPD、类风湿性关节炎和癌症方面有用。